Get the Stockscreener App
26.00
7.42%
1.83
Procept Biorobotics Corp stock is traded at $26.00, with a volume of 1.40M.
It is up +7.42% in the last 24 hours and down -8.90% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$24.17
Open:
$24.13
24h Volume:
1.40M
Relative Volume:
0.91
Market Cap:
$1.47B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-15.29
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-2.24%
1M Performance:
-8.90%
6M Performance:
-32.80%
1Y Performance:
-56.41%
1-Day Range:
$23.71
$26.20
1-Week Range:
$22.77
$27.00
52-Week Range:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
26.02 | 1.36B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
110.17 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.81 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.82 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.61 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com Nigeria
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Australia
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $163,340.40 in Stock - MarketBeat
Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com India
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Blair William & Co. IL Purchases 169,237 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Adds Independent Director to Audit Committee - The Globe and Mail
Baird Initiates Coverage of PROCEPT BioRobotics (PRCT) with Neutral Recommendation - Nasdaq
Baird initiates Procept BioRobotics stock rating at Neutral By Investing.com - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6.9%Time to Sell? - MarketBeat
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Robert W. Baird Initiates Coverage on PROCEPT BioRobotics (NASDAQ:PRCT) - MarketBeat
Procept Biorobotics Corporation Appoints Daniel Puckett Board and Audit Committee Member, Effective March 5, 2026 - marketscreener.com
PRCT: Baird Initiates Neutral Rating with $30 Price Target | PRC - GuruFocus
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
Procept BioRobotics initiated with a Neutral at Baird - TipRanks
A Look At PROCEPT BioRobotics (PRCT) Valuation After Earnings Miss And New 2026 To 2027 Guidance - simplywall.st
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - PR Newswire
Procept BioRobotics Balances Rapid Growth With Profit Push - TipRanks
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $19.35 - Markets Mojo
PROCEPT BioRobotics Stock Hits Day Low of $19.35 Amid Price Pressure - Markets Mojo
PROCEPT BioRobotics Faces Weak Start with 30.5% Gap Down Amid Market Concerns - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 56,967 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Champlain Investment Partners LLC Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Citigroup Inc. Purchases 45,979 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects - 富途牛牛
PROCEPT BioRobotics (+14%): Cowen Conference Rebound After Earnings Sell-Off - Trefis
PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics - DirectorsTalk Interviews
William Blair Investment Management LLC Purchases 54,396 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Vanguard Group Inc. Sells 42,630 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept BioRobotics price target lowered to $30 from $47 at Truist - Yahoo Finance
PRCT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus By Investing.com - Investing.com Nigeria
Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus - Investing.com
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Up 9.9%Here's Why - MarketBeat
JPMorgan Chase & Co. Cuts Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Cowen Maintains Buy on PRCT PROCEPT BioRobotics Corporation Feb 2026 - Meyka
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):